Systematic Review
Published on 19 Jul 2019
Intensive Monitoring Studies for Assessing Medicines: A Systematic Review
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2019.00147
- 9,148 views
- 6 citations
- Frontiers in Medicine
- Regulatory Science
- Articles
Type at least 3 characters
520 articles
articles
Policy and Practice Reviews
Published on 10 Jul 2019
Canada's Assisted Human Reproduction Act: Pragmatic Reforms in Support of Research
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2019.00157
- 12,036 views
- 8 citations
Editorial
Published on 03 Jul 2019
Editorial: Drug Repurposing
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2019.00154
- 5,099 views
- 7 citations
Review
Published on 27 Jun 2019
The Iterative Development of Medicines Through the European Medicine Agency's Adaptive Pathway Approach
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2019.00148
- 9,147 views
- 21 citations
Editorial
Published on 31 May 2019
Editorial: Public-Private Partnerships as Drivers of Innovation in Healthcare
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2019.00114
- 9,779 views
- 19 citations
Perspective
Published on 14 May 2019
From Opioid Pain Management to Opioid Crisis in the USA: How Can Public-Private Partnerships Help?
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2019.00106
- 14,405 views
- 9 citations
Original Research
Published on 07 May 2019
Alignment of European Regulatory and Health Technology Assessments: A Review of Licensed Products for Alzheimer's Disease
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2019.00073
- 8,149 views
- 13 citations
Hypothesis and Theory
Published on 24 Apr 2019
Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2019.00082
- 16,013 views
- 56 citations
Original Research
Published on 03 Apr 2019
The Patient Perspectives on Future Therapeutic Options in NASH and Patient Needs
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2019.00061
- 11,017 views
- 34 citations
Original Research
Published on 29 Mar 2019
Direct-to-Consumer Genetic Testing's Red Herring: “Genetic Ancestry” and Personalized Medicine
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2019.00048
- 24,242 views
- 37 citations
Policy and Practice Reviews
Published on 28 Mar 2019
Recommendations for Regulating the Environmental Risk of Shedding for Gene Therapy and Oncolytic Viruses in Canada
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2019.00058
- 12,502 views
- 8 citations
Editorial
Published on 08 Nov 2018
Editorial: The European Patients Academy on Therapeutic Innovation (EUPATI) Guidelines on Patient Involvement in Research and Development
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2018.00310
- 4,866 views
- 18 citations
Original Research
Published on 11 Oct 2018
Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2018.00285
- 9,370 views
- 17 citations
Policy and Practice Reviews
Published on 09 Oct 2018
EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2018.00270
- 18,352 views
- 57 citations
Policy and Practice Reviews
Published on 25 Sep 2018
Regulatory Pathway for Licensing Biotherapeutics in Mexico
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2018.00272
- 15,011 views
- 6 citations
Original Research
Published on 20 Sep 2018
What Is Health Information Quality? Ethical Dimension and Perception by Users
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2018.00260
- 7,744 views
- 26 citations
Policy and Practice Reviews
Published on 07 Sep 2018
EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2018.00251
- 12,018 views
- 31 citations
Policy and Practice Reviews
Published on 06 Sep 2018
EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2018.00231
- 18,694 views
- 70 citations
Policy and Practice Reviews
Published on 17 Aug 2018
EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2018.00230
- 13,774 views
- 64 citations
Original Research
Published on 12 Jun 2018
Retrospective Study of Reported Adverse Events Due to Complementary Health Products in Singapore From 2010 to 2016
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2018.00167
- 10,408 views
- 20 citations
Perspective
Published on 28 May 2018
Cell and Gene Therapies: European View on Challenges in Translation and How to Address Them
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2018.00158
- 8,823 views
- 20 citations
Review
Published on 09 Mar 2018
Getting Digital Assets from Public–Private Partnership Research Projects through “The Valley of Death,” and Making Them Sustainable
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2018.00065
- 9,435 views
- 12 citations
Methods
Published on 22 Feb 2018
Evidence Synthesis in Harm Assessment of Medicines Using the Example of Rosiglitazone and Myocardial Infarction
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2017.00228
- 3,598 views
- 1 citation
Original Research
Published on 29 Jan 2018
Toward a Tiered Model to Share Clinical Trial Data and Samples in Precision Oncology
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2018.00006
- 7,508 views
- 17 citations